Abstract
The structure and function of a 27-a.a. fragment of the N-terminal sequence of human endostatin (ES-Zn) were compared to those of the mutant peptide (ES-SSZn) obtained by adding Cys-Pro-Ala to the endostatin N-terminus and substituting Asn16 for Cys ensuring formation of a disulfide bond. Structural comparison of ES-Zn and ES-SSZn by far-UV circular dichroism (CD), intrinsic fluorescence, and molecular dynamics simulation methods revealed significant structural perturbations in ES-SSZn, such as elimination of the β-sheet conformer, modification of the N-terminal loop structure, and reorganization of dynamic properties of the entire peptide backbone. ES-SSZn was approximately 2 and 3 times less efficient than ES-Zn and the full-length human endostatin, respectively, in the induction of caspase-3-dependent apoptosis in human umbilical vein endothelial cells (HUVECs) in vitro (p < 0.05). In contrast, treatment of metastatic 4T1 breast tumors in mice with ES-Zn and ES-SSZn (5 mg/kg body weight daily) for 14 days resulted in similar regression of tumor size, comparable downregulation of angiogenesis (CD31 and CD34) and cell proliferation (Ki67), and therefore, the same extent of apoptosis induction (TUNEL, p53, and Bcl-2) for both peptides (as compared to the untreated controls). Western blot analysis of HUVEC and 4T1 tumor lysates revealed the same levels of suppression of key signaling mediators Akt and ERK1/2 by ES-Zn and ES-SSZn. Contrary to the earlier studies, our results showed that the function of the 1-27 endo-statin fragment is independent of its overall structure. Stabilization of the N-terminal loop structure by the disulfide bond incorporation causes relief from structural deviations.
Similar content being viewed by others
Abbreviations
- Akt:
-
serine/threonine protein kinase B
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- DSSP:
-
dictionary of secondary structure of proteins (hydrogen bond estimation algorithm)
- ERK1/2:
-
extracellular signal-regulated kinase 1/2
- ES-Zn:
-
a 27-a.a. fragment of the N-terminal sequence of endo-statin
- ES-SSZn:
-
mutant peptide derived by addition of Cys-Pro-Ala to the N-terminus of ES-Zn peptide and substitution of Asn16 for Cys required for the disulfide bond formation
- HUVECs:
-
human umbilical vein endothelial cells
- MAPK:
-
mitogen-activated protein kinase
- MD:
-
molecular dynamics
- PBS:
-
phosphate buffered saline
- PI3K:
-
phosphoinositide 3-kinase
- RMSD:
-
root mean square deviation
- RMSF:
-
root mean square fluctuation
- TUNEL:
-
terminal deoxynucleotidyl trans-ferase-mediated dUTP nick end labeling
References
O’Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth, Cell, 88, 277–285.
Folkman, J. (2006) Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action, Exp. Cell. Res., 312, 594–607.
Ding, Y. H., Javaherian, K., Lo, K. M., Chopra, R., Boehm, T., Lanciotti, J., Harris, B. A., Li, Y., Shapiro, R., Hohenester, E., Timpl, R., Folkman, J., and Wiley, D. C. (1998) Zinc dependent dimers observed in crystals of human endostatin, Proc. Natl. Acad. Sci. USA, 95, 10443–10448.
Hohenester, E., Sasaki, T., Olsen, B. R., and Timpl, R. (1998) Crystal structure of the angiogenesis inhibitor endo-statin at 1.5 Е resolution, EMBO J., 17, 1656–1664.
Fu, Y., and Luo, Y. (2010) The N-terminal integrity is critical for the stability and biological functions of endostatin, Biochemistry, 49, 6420–6429.
Boehm, T., O’Reilly, M. S., Keough, K., Shiloach, J., Shapiro, R., and Folkman, J. (1998) Zinc-binding of endo-statin is essential for its anti-angiogenic activity, Biochem. Biophys. Res. Commun., 252, 190–194.
Hohenester, E., Sasaki, T., Mann, K., and Timpl, R. (2000) Variable zinc coordination in endostatin, J. Mol. Biol., 297, 1–6.
Tjin Tham Sjin, R. M., Satchi-Fainaro, R., Birsner, A. E., Ramanujam, V. M., Folkman, J., and Javaherian, K. (2005) A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its anti-tumor activity, Cancer Res., 65, 3656–3663.
Chamani, R., Asghari, S. M., Alizadeh, A. M., Eskandari, S., Mansouri, K., Khodarahmi, R., Taghdir, M., Heidari, Z., Gorji, A., Aliakbar, A., Ranjbar, B., and Khajeh, K. (2015) Engineering of a disulfide loop instead of a Zn bind-ing loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endo-statin: mechanistic and therapeutic insights, Vasc. Pharmacol., 72, 73–82.
Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma, N. Engl. J. Med., 324, 1–8.
Hammond, J. B., and Kruger, N. J. (1988) The Bradford method for protein quantitation, Methods Mol. Biol., 3, 25–32.
Mostafaie, A., Bidmeshkipour, A., Shirvani, Z., Mansouri, K., and Chalabi, M. (2008) A proper new collagenase for isolation of cells from different tissue, Appl. Biochem. Biotechnol., 144, 123–131.
Chamani, R., Asghari, S. M., Alizadeh, A. M., Mansouri, K., Doroudi, T., Kolivand, P. H., Ghafouri, H., Ehtesham, S., Rabouti, H., and Mehrnejad, F. (2016) The antiangiogenic and antitumor activities of the N-terminal fragment of endostatin augmented by Ile/Arg substitution: the over-all structure implicated the biological activity, Biochim. Biophys. Acta, 1864, 1765–1774.
Khori, V., Amani Shalamzari, S., Isanejad, A., Alizadeh, A. M., Alizadeh, S., Khodayari, S., Khodayari, H., Shahbazi, S., Zahedi, A., Sohanaki, H., Khaniki, M., Mahdian, R., Saffari, M., and Fayad, R. (2015) Effects of exercise training together with tamoxifen in reducing mammary tumor burden in mice: possible underlying pathway of miR-21, Eur. J. Pharmacol., 765, 179–187.
Lanari, C., Luthy, I., Lamb, C. A., Fabris, V., Pagano, E., Helguero, L. A., Sanjuan, N., Merani, S., and Molinolo, A. A. (2001) Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins, Cancer Res., 61, 293–302.
Mohsenikia, M., Alizadeh, A. M., Khodayari, S., Khodayari, H., Kouhpayeh, S. A., Karimi, A., Zamani, M., Azizian, S., and Mohagheghi, M. A. (2013) The protective and therapeutic effects of alpha-solanine on mice breast cancer, Eur. J. Pharmacol., 718, 1–9.
Comeau, S. R., Gatchell, D. W., Vajda, S., and Camacho, C. J. (2004) ClusPro: a fully automated algorithm for protein-protein docking, Nucleic Acids Res., 32, 96–99.
Comeau, S. R., Gatchell, D. W., Vajda, S., and Camacho, C. J. (2004) ClusPro: an automated docking and discrimination method for the prediction of protein complexes, Bioinformatics, 20, 45–50.
Sali, A., and Blundell, T. L. (1993) Comparative protein modelling by satisfaction of spatial restraints, J. Mol. Biol., 234, 779–815.
Van der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., and Berendsen, H. J. (2005) GROMACS: fast, flexible, and free, J. Comput. Chem., 26, 1701–1718.
Hess, B., Kutzner, C., van der Spoel, D., and Lindahl, E. (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation, J. Chem. Theor. Comput., 4, 435–447.
Kabsch, W., and Sander, C. (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features, Biopolymers, 22, 2577–2637.
Kang, H. Y., Shim, D., Kang, S. S., Chang, S. I., and Kim, H. Y. (2006) Protein kinase B inhibits endostatin-induced apoptosis in HUVECs, J. Biochem. Mol. Biol., 39, 97–104.
Yuan, S., Fu, Y., Wang, X., Shi, H., Huang, Y., Song, X., Li, L., Song, N., and Luo, Y. (2008) Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis, FASEB J., 22, 2809–2820.
Folkman, J. (2003) Angiogenesis and apoptosis, Semin. Cancer Biol., 13, 159–167.
Miyashita, T., and Reed, J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, 80, 293–299.
Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. (1994) Down-regulation of bcl-2 by p53 in breast cancer cells, Cancer Res., 54, 2095–2097.
Simons, M., Emma Gordon, E., and Welsh, L. C. (2016) Mechanisms and regulation of endothelial VEGF receptor signaling, Nat. Rev. Mol. Cell Biol., 17, 611–625.
Hong, C. C., Peterson, Q. P., Hong, J. Y., and Peterson, R. T. (2006) Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK1/2 signaling, Curr. Biol., 16, 1366–1372.
Murakami, M. (2011) FGF-dependent regulation of VEGF receptor 2 expression in mice, J. Clin. Invest., 121, 2668–2678.
Shiojima, I., and Walsh, K. (2002) Role of Akt signaling in vascular homeostasis and angiogenesis, Circ. Res., 90, 1243–1250.
Olsson, A. K., Dimberg, A., Kreuger, J., and Welsh, L. C. (2016) VEGF receptor signalling-in control of vascular function, Nat. Rev. Mol. Cell Biol., 7, 359–371.
Krock, B. L., Skuli, N., and Simon, M. C. (2011) Hypoxia-induced angiogenesis: good and evil, Genes Cancer, 2, 1117–1133.
Zheng, J. H., Viacava, F. A., Kriwacki, R. W., and Moldoveanu, T. (2016) Discoveries and controversies in BCL-2 protein-mediated apoptosis, FEBS J., 283, 2690–2700.
Hsu, M. J., Wu, C. Y., Chiang, H. H., Lai, Y. L., and Hung, S. L. (2010) PI3K/Akt signaling mediated apoptosis blockage and viral gene expression in oral epithelial cells during herpes simplex virus infection, J. Virus Res., 153, 36–43.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Published in Russian in Biokhimiya, 2018, Vol. 83, No. 11, pp. 1708–1721.
Rights and permissions
About this article
Cite this article
Ehtesham, S., Sariri, R., Eidi, A. et al. Effect of Disulfide Bond Incorporation on the Structure and Activity of Endostatin Peptide. Biochemistry Moscow 83, 1388–1398 (2018). https://doi.org/10.1134/S0006297918110093
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297918110093